How does hpv cause cervical cancer

Content on WhatAnswers is provided "as is" for informational purposes. While we strive for accuracy, we make no guarantees. Content is AI-assisted and should not be used as professional advice.

Last updated: April 8, 2026

Quick Answer: HPV causes cervical cancer when persistent infection with high-risk HPV types leads to cellular changes in the cervix. Approximately 99.7% of cervical cancer cases are linked to HPV infection, with types 16 and 18 responsible for about 70% of cases. The virus integrates into host DNA, disrupting tumor suppressor genes like p53 and Rb, which normally control cell growth. This process typically takes 10-20 years from initial infection to cancer development.

Key Facts

HPV is responsible for 99.7% of cervical cancer cases worldwide
HPV types 16 and 18 cause approximately 70% of cervical cancers
The progression from HPV infection to cervical cancer typically takes 10-20 years
Cervical cancer is the fourth most common cancer in women globally, with 604,000 new cases in 2020
HPV vaccination can prevent up to 90% of HPV-related cancers when administered before exposure

Overview

Human papillomavirus (HPV) is the primary cause of cervical cancer, with the link first established in the 1970s by German virologist Harald zur Hausen, who won the 2008 Nobel Prize for this discovery. Cervical cancer was once the leading cause of cancer death in women in the United States before widespread Pap smear screening began in the 1950s. Globally, cervical cancer remains a major health concern, particularly in low-resource countries where screening and vaccination programs are limited. The World Health Organization reports approximately 604,000 new cases and 342,000 deaths from cervical cancer in 2020, making it the fourth most common cancer in women worldwide. HPV is a common sexually transmitted infection, with most sexually active individuals contracting at least one type during their lifetime, though most infections clear spontaneously within 1-2 years without causing cancer.

How It Works

HPV causes cervical cancer through a multi-step process beginning with infection of basal epithelial cells in the cervical transformation zone. High-risk HPV types (particularly 16 and 18) produce viral oncoproteins E6 and E7 that interfere with normal cell cycle regulation. E6 binds to and degrades the tumor suppressor protein p53, which normally triggers apoptosis in damaged cells, while E7 inactivates the retinoblastoma protein (Rb), disrupting cell cycle control. This leads to uncontrolled cell proliferation and genomic instability. Over time, persistent infection causes cervical intraepithelial neoplasia (CIN), progressing from low-grade to high-grade lesions. If untreated, these precancerous changes can develop into invasive squamous cell carcinoma or adenocarcinoma, typically over 10-20 years. The virus integrates into the host genome, further disrupting normal cellular functions and promoting malignant transformation.

Why It Matters

Cervical cancer prevention through HPV vaccination and screening represents one of the most significant public health achievements in cancer control. The HPV vaccine, first approved in 2006, can prevent up to 90% of HPV-related cancers when administered before exposure. Regular Pap smears and HPV testing have reduced cervical cancer incidence by over 50% in countries with established screening programs. Despite these advances, disparities persist globally, with 90% of cervical cancer deaths occurring in low- and middle-income countries. The WHO launched a global strategy in 2020 to eliminate cervical cancer as a public health problem, aiming for 90% vaccination coverage, 70% screening rates, and 90% treatment access by 2030. Understanding HPV's role in cervical cancer has transformed prevention from reactive treatment to proactive vaccination and early detection.